Your browser doesn't support javascript.
loading
Genetic markers and phosphoprotein forms of beta-catenin pß-Cat552 and pß-Cat675 are prognostic biomarkers of cervical cancer.
Scholl, Suzy M; Beal, Jonas; de Koning, Leanne; Girard, Elodie; Popovic, Marina; de la Rochefordière, Anne; Lecuru, Fabrice; Fourchotte, Virginie; Ngo, Charlotte; Floquet, Anne; Berns, Els Mjj; Kenter, Gemma; Gestraud, Pierre; von der Leyen, Heiko; Lecerf, Charlotte; Puard, Vincent; Roman, Sergio Roman; Latouche, Aurelien; Kereszt, Attila; Balint, Balazs; Rouzier, Roman; Kamal, Maud.
Afiliación
  • Scholl SM; Department of Drug Development and Innovation, Institut Curie, PSL Research University, 75005 Paris & 92210 Saint-Cloud, France. Electronic address: suzy.scholl@gmail.com.
  • Beal J; Bioinformatics and Computational Systems Biology of Cancer, PSL Research University, Mines Paris Tech, INSERM U900, 75005 Paris, France.
  • de Koning L; Department of Translational Research, Institut Curie, PSL Research University, 75005 Paris & 92210 Saint-Cloud, France.
  • Girard E; Bioinformatics and Computational Systems Biology of Cancer, PSL Research University, Mines Paris Tech, INSERM U900, 75005 Paris, France.
  • Popovic M; Oncology Institute of Vojvodina, Put doktora Goldmana, 421204 Sremska Kamenica, Serbia.
  • de la Rochefordière A; Department of Radiotherapy, Institut Curie, PSL Research University, 75005 Paris, France.
  • Lecuru F; Department of Surgery, Institut Curie, PSL Research University, PSL Research University, 75005 Paris & 92210 Saint-Cloud, France.
  • Fourchotte V; Department of Surgery, Institut Curie, PSL Research University, PSL Research University, 75005 Paris & 92210 Saint-Cloud, France.
  • Ngo C; Service de chirurgie cancérologique gynécologique et du sein, Hôpital Européen Georges Pompidou, APHP et faculté de médecine, Université Paris Descartes, France.
  • Floquet A; Chirurgie onco-gynécologique and Oncology, Institut Bergonié, Centre Régional de Lutte contre le Cancer Bordeaux-Aquitaine, France.
  • Berns EM; Dept Medical Oncology, Erasmus MC, 3000 CA Rotterdam, Netherlands.
  • Kenter G; Department of Drug Development and Innovation, Institut Curie, PSL Research University, 75005 Paris & 92210 Saint-Cloud, France; Department of Gynaecologic Oncology Amsterdam, Amsterdam UMC and The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands.
  • Gestraud P; Bioinformatics and Computational Systems Biology of Cancer, PSL Research University, Mines Paris Tech, INSERM U900, 75005 Paris, France.
  • von der Leyen H; Department of Drug Development and Innovation, Institut Curie, PSL Research University, 75005 Paris & 92210 Saint-Cloud, France; Hannover Clinical Trial Center, Hannover Medical School Germany.
  • Lecerf C; Department of Drug Development and Innovation, Institut Curie, PSL Research University, 75005 Paris & 92210 Saint-Cloud, France.
  • Puard V; Department of Translational Research, Institut Curie, PSL Research University, 75005 Paris & 92210 Saint-Cloud, France.
  • Roman SR; Department of Translational Research, Institut Curie, PSL Research University, 75005 Paris & 92210 Saint-Cloud, France.
  • Latouche A; Bioinformatics and Computational Systems Biology of Cancer, PSL Research University, Mines Paris Tech, INSERM U900, 75005 Paris, France; Conservatoire national des arts et métiers, Paris, France.
  • Kereszt A; Department of Drug Development and Innovation, Institut Curie, PSL Research University, 75005 Paris & 92210 Saint-Cloud, France; SeqOmics Biotechnology Ltd, Vallalkozok utja 7, Morahalom, Hungary.
  • Balint B; Department of Drug Development and Innovation, Institut Curie, PSL Research University, 75005 Paris & 92210 Saint-Cloud, France; Department of Translational Research, Institut Curie, PSL Research University, 75005 Paris & 92210 Saint-Cloud, France.
  • Rouzier R; Department of Surgery, Institut Curie, PSL Research University, PSL Research University, 75005 Paris & 92210 Saint-Cloud, France; Bioinformatics and Computational Systems Biology of Cancer, PSL Research University, Mines Paris Tech, INSERM U900, 75005 Paris, France.
  • Kamal M; Department of Drug Development and Innovation, Institut Curie, PSL Research University, 75005 Paris & 92210 Saint-Cloud, France.
EBioMedicine ; 61: 103049, 2020 Nov.
Article en En | MEDLINE | ID: mdl-33096476
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Biomarcadores de Tumor / Marcadores Genéticos / Neoplasias del Cuello Uterino / Beta Catenina Tipo de estudio: Prognostic_studies Límite: Female / Humans Idioma: En Revista: EBioMedicine Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Biomarcadores de Tumor / Marcadores Genéticos / Neoplasias del Cuello Uterino / Beta Catenina Tipo de estudio: Prognostic_studies Límite: Female / Humans Idioma: En Revista: EBioMedicine Año: 2020 Tipo del documento: Article